340 related articles for article (PubMed ID: 32473611)
21. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
22. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
Ren F; Wang DB; Li T
Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):822-5. PubMed ID: 22333230
[TBL] [Abstract][Full Text] [Related]
23. A mouse model of endometriosis mimicking the natural spread of invasive endometrium.
Wilson MR; Holladay J; Chandler RL
Hum Reprod; 2020 Jan; 35(1):58-69. PubMed ID: 31886851
[TBL] [Abstract][Full Text] [Related]
24. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathogenesis of ovarian clear cell carcinoma.
Gounaris I; Brenton JD
Future Oncol; 2015; 11(9):1389-405. PubMed ID: 25952785
[TBL] [Abstract][Full Text] [Related]
26. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ; Shih IeM
Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
[TBL] [Abstract][Full Text] [Related]
27. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
28. [Preneoplasias of ovarian carcinoma: biological and clinical aspects of different pathways of tumorigenesis].
Staebler A
Pathologe; 2011 Nov; 32 Suppl 2():265-70. PubMed ID: 21809064
[TBL] [Abstract][Full Text] [Related]
29. Cancer-Associated Mutations in Endometriosis without Cancer.
Anglesio MS; Papadopoulos N; Ayhan A; Nazeran TM; Noë M; Horlings HM; Lum A; Jones S; Senz J; Seckin T; Ho J; Wu RC; Lac V; Ogawa H; Tessier-Cloutier B; Alhassan R; Wang A; Wang Y; Cohen JD; Wong F; Hasanovic A; Orr N; Zhang M; Popoli M; McMahon W; Wood LD; Mattox A; Allaire C; Segars J; Williams C; Tomasetti C; Boyd N; Kinzler KW; Gilks CB; Diaz L; Wang TL; Vogelstein B; Yong PJ; Huntsman DG; Shih IM
N Engl J Med; 2017 May; 376(19):1835-1848. PubMed ID: 28489996
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.
Gan M; Tai Z; Yu Y; Zhang C; Xu J
PeerJ; 2023; 11():e14653. PubMed ID: 36721777
[TBL] [Abstract][Full Text] [Related]
31. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
[TBL] [Abstract][Full Text] [Related]
32. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
Kato N; Sasou S; Motoyama T
Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
[TBL] [Abstract][Full Text] [Related]
33. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary.
Taniguchi F; Itamochi H; Harada T; Terakawa N
Int J Gynecol Cancer; 2013 Jun; 23(5):791-6. PubMed ID: 23640291
[TBL] [Abstract][Full Text] [Related]
35. ARID1A protein expression is retained in ovarian endometriosis with ARID1A loss-of-function mutations: implication for the two-hit hypothesis.
Yachida N; Yoshihara K; Suda K; Nakaoka H; Ueda H; Sugino K; Yamaguchi M; Mori Y; Yamawaki K; Tamura R; Ishiguro T; Isobe M; Motoyama T; Inoue I; Enomoto T
Sci Rep; 2020 Aug; 10(1):14260. PubMed ID: 32868822
[TBL] [Abstract][Full Text] [Related]
36. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
[TBL] [Abstract][Full Text] [Related]
37. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
[TBL] [Abstract][Full Text] [Related]
38. Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
Samartzis EP; Samartzis N; Noske A; Fedier A; Caduff R; Dedes KJ; Fink D; Imesch P
Mod Pathol; 2012 Jun; 25(6):885-92. PubMed ID: 22301703
[TBL] [Abstract][Full Text] [Related]
39. Distinguishing the progression of an endometrioma: Benign or malignant?
Bastu E; Onder S; Demiral I; Ozsurmeli M; Keskin G; Takmaz O; Ozaltin S; Gorgen H; Gungor M; Yavuz E; Buyru F
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():79-84. PubMed ID: 30245441
[TBL] [Abstract][Full Text] [Related]
40. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]